Navigation Links
Biggest Names in Pharmaceutical, Healthcare Industry to Gather for Groundbreaking Event in Parsippany, New Jersey on September 11-12, 2012
Date:6/27/2012

PARSIPPANY, N.J., June 27, 2012 /PRNewswire/ -- For professionals seeking the latest in pharmaceuticals, healthcare, biotech, and devices, the hottest ticket is the Pharma CI Conference & Exhibition on September 11-12, 2012 in Parsippany, New Jersey, USA (http://pharmaciconference.com/ ).

"Under the guidance of conference co-chairs representing high-level leadership at Merck and Pfizer, this event offers the very best in pharmaceutical competitive intelligence," says Amy Yueh, the conference organizer. Conference participants will clearly benefit from the talented speaking faculty of 75+ expert speakers from prestigious companies like Actelion, AstraZeneca, Bausch + Lomb, Bayer Healthcare, Boehringer Ingelheim Pharmaceuticals, Inc., CSL Behring, DSM Pharmaceutical Products, Endo Pharmaceuticals Inc., Eisai, Inc., Genzyme, Helsinn Healthcare S.A., Janssen Global Services, Johnson and Johnson, Medtronic Inc., Merck & Co., Inc., Merrimack Pharmaceuticals, Onyx Pharmaceuticals, Pfizer Inc., Philips Healthcare, Roche, sanofi aventis, Takeda, Teva Global Branded Products, Upsher-Smith Laboratories, Valeant Pharmaceuticals, Vertex Pharmaceuticals Inc, and many more! To see the impressive speaker bios, go to: http://pharmaciconference.com/Speakers

"Your conference brings together the best of the Pharma CI community. I wouldn't miss it," said a Boehinger Ingelheim participant.

"Extremely interesting conference, very relevant for CI professionals and a great opportunity to exchange ideas and challenges," said a Sanofi Aventis participant.

More than 300 influential pharmaceutical executives attended the sold-out event last year! This is the only place for pharma decision makers to network and discuss real-world solutions. The 50+ sessions on all the industry's most pressing issues are delved into in the comprehensive program agenda ('/>"/>

SOURCE Pharma CI Conference
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMotiv Launches Novel Drug Development Operation, Names Leadership Team
2. Sapphire Energy Names New Scientific Advisory Board
3. CAS Names 2012 SciFinder® Future Leaders in Chemistry Program Participants
4. OrthoAccel Technologies, Inc. Names U.S. National Sales Director
5. Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board
6. China Biologic Products Names Chairman David Gao to Additional Post of CEO
7. Diagnostic Marketing Association Names Cepheid 2011 Marketer of the Year
8. RIFM Board Names New President
9. Hospira Names John B. Elliot Senior Vice President of Operations
10. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
11. Laureate Biopharma Names James D. Utterback to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Selexis SA, a serial ... Cell Banks (RCBs) used for drug discovery to commercial ... will include Next-Generation Sequencing (NGS) data packages. ... biologic manufacturing by ensuring the integrity of the gene, ...
(Date:1/22/2015)... Nueva Jersey , 22 de enero de 2015  El ... abre hoy su llamada a nominaciones para 2015. Este ... ha hecho, o tiene el potencial para hacer, contribuciones ... nominaciones se aceptarán hasta el 15 de marzo de ...
(Date:1/22/2015)... Jan. 22. 2015  Varian Medical Systems (NYSE: VAR ... honored for its commitment to sustainability with inclusion on a ... the highest ranked healthcare equipment company among the Corporate Knights ... World Economic Forum at Davos, Switzerland . ...
(Date:1/22/2015)... 22, 2015  Derma Sciences, Inc. (Nasdaq: ... advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, ... added to the Premier, Inc. Regenerative Skin Grafting ... the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
... development places National Stem Cell in the sector for Anti-aging, ... and one of the ... Today, MOUNTAINSIDE, N.J., Oct. 25 National Stem,Cell Holding, ... is currently in final stage negotiations to exclusively license one ...
... Mass., Oct. 25 Millennium,Pharmaceuticals, Inc. (Nasdaq: ... a,conference call at 8:00 a.m. ET on Thursday, ... third-quarter 2007 financial and,operational results and upcoming activities. ... available on the webcast. Prior to the,conference call ...
... Glycominds Ltd., a,bio-diagnostics company specializing in glycan ... and cancer, announced today,entering into a research agreement ... cancer center to develop a new diagnostics blood ... to work with FCCC on this project," stated ...
Cached Biology Technology:National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti-Aging Applications 2Millennium to Webcast Third-Quarter 2007 Financial and Operational Results 2Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests 2
(Date:12/11/2014)... Research and Markets , ... announced the addition of the "Biometrics Market in ... One major trend emerging in this market ... it is important to upgrade biometric solutions to the ...
(Date:12/11/2014)... ST. PAUL, Minn. , Dec. 10, 2014 ... wireless physiologic monitoring, has released a new series ... needs of preclinical toxicology researchers. M series, part ... help toxicologists collect the best possible physiologic data ...
(Date:12/10/2014)...  Wake Forest Baptist Medical Center today announced plans for a ... for this $50 million capital project is part of a ... The medical education building will be located ... adjacent to 525@vine in Wake Forest Innovation Quarter. Construction will ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... Native Americans may have roots in the evolutionary past. "Thrifty" ... famine may contribute to diabetes in modern times of plenty. ... an Arizona cave suggests that the evolution of thrifty genes ... do with the nature of the ancient feast. The research, ...
... Ribbon Panel, commissioned by the White House Office ... National Science Foundation (NSF) released their report, More ... Effectiveness. The report is a comprehensive document based ... recommendations for the U.S. logistics system for improved ...
... The Wyss Institute for Biologically Inspired Engineering at ... into a Cooperative Agreement worth up to $37 ... (DARPA) to develop an automated instrument that integrates ... outside the body. This effort builds on ...
Cached Biology News:Feces fossils yield new insights into ancient diets and 'thrifty genes' 2Feces fossils yield new insights into ancient diets and 'thrifty genes' 3Blue Ribbon Panel unveils findings on logistical improvements to support Antarctic science 2Wyss Institute receives up to $37 million from DARPA to integrate organ chips to mimic the human body 2Wyss Institute receives up to $37 million from DARPA to integrate organ chips to mimic the human body 3
Rabbit polyclonal to FOXJ2 ( Abpromise for all tested applications). entrezGeneID: 55810 SwissProtID: Q9P0K8...
Selenoprotein P Purified Anti-Mouse clone 35, Isotype Mouse IgG 2b , 50 µg Consult technical datasheet for details....
Mouse monoclonal [3B6] to HSV1 + HSV2 ICP5 Major Capsid Protein ( Abpromise for all tested applications)....
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate...
Biology Products: